About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Early Airway Response to Allergen in Asthmatics (MK-0000-176)

NCT01061333·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Merck Sharp & Dohme LLC

Age

18–55

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

History of mild to moderate Asthma
In good general health (except for asthma)
Stable and free of respiratory infection
Nonsmoker
Females highly unlikely to conceive (surgically sterilized, postmenopausal, or agrees to use 2 acceptable methods of birth control)

You may not be if

Nursing mother
Recent or ongoing upper or lower respiratory tract infection
Unable to refrain from or anticipates the use of any prescription and non-prescription drugs
Consumes excessive amounts of alcohol or caffeine
History of stroke, chronic seizures, or major neurological disorder
History of cancer
Received a vaccination within the past 3 weeks

The record

StatusCompleted

PhasePhase 1

Taking part16

StartedJun 2010

UpdatedSep 4, 2015

Conditions

Clareo Health | Early Airway Response to Allergen in Asthmatics (MK-0000-176)